Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 16,835,801
Avg Vol 2,787,720
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 38%
Beta N/A
Analysts Strong Buy
Price Target N/A
Latest News on RNAM
3 Investable Laggards In An Overbought Market

Oct 28, 2025, 5:13 PM EDT - 4 months ago

3 Investable Laggards In An Overbought Market

AVDL BMY ETNB MRUS MTSR NVS PAGP


Avidity Biosciences Soars After $72 Per Share Novartis Takeover

Oct 27, 2025, 2:52 PM EDT - 4 months ago

Avidity Biosciences Soars After $72 Per Share Novartis Takeover

NVS


Is it too late to buy Avidity stock after Novartis deal?

Oct 27, 2025, 10:22 AM EDT - 4 months ago

Is it too late to buy Avidity stock after Novartis deal?


Novartis Agrees $12 Billion Biotech Deal for Avidity

Oct 27, 2025, 4:59 AM EDT - 4 months ago

Novartis Agrees $12 Billion Biotech Deal for Avidity

NVS


Novartis Agrees to Acquire Avidity Biosciences for $12 Billion

Oct 26, 2025, 5:33 PM EDT - 4 months ago

Novartis Agrees to Acquire Avidity Biosciences for $12 Billion

NVS


Novartis to acquire Avidity Biosciences for about $12B

Oct 26, 2025, 3:46 PM EDT - 4 months ago

Novartis to acquire Avidity Biosciences for about $12B

NVS


Novartis Deal Values Avidity Biosciences At $12 Billion

Oct 26, 2025, 3:29 PM EDT - 4 months ago

Novartis Deal Values Avidity Biosciences At $12 Billion

NVS


Novartis to acquire Avidity Biosciences for $12 billion

Oct 26, 2025, 1:07 PM EDT - 4 months ago

Novartis to acquire Avidity Biosciences for $12 billion

NVS